Prime Medicine (NASDAQ:PRME) continues to strengthen its presence in biotechnology and among healthcare stocks. The company’s ...

The clinical success of CRISPR-based treatments is fundamentally dependent on sophisticated gRNA targeting systems that ...

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...

Treatment introduces an expansion of the scope of gene therapies that might lead to similar treatments for neurodegenerative ...

Scientists have discovered a way to make gene editing safer and more precise — and it's an advance that could help bolster ...

Creative Bioarray, a leading provider of life science research tools and services, today announced the launch of its comprehensive, customer-tailored cell line establishment service.

"RUBY"—a cost-effective innovation designed to track gene activity—is proving valuable across a range of fields. It all ...

Onboard the International Space Station (ISS), mutant mice have been the focus of significant research. These studies explore ...

Creative Biogene, one of the leaders in biotechnology solutions, is excited to announce the release of its customized genetic engineering services for Lactobacillus plantarum.

A Cairns biotech startup is combining Indigenous knowledge of "rainmaking" with modern science to develop an electrical seed ...

Some leading organizations in the field of cell and gene therapies recently issued a call for a 10-year international moratorium delay on the use of CRISPR. That's the scissoring techniques used to ...

The Cell and Gene Therapy Catapult and pHion Therapeutics announced an exclusive licence agreement for pHion’s proprietary RALA technology for ex-vivo applications. The agreement builds upon the ...